These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 31132474)
1. A real world evaluation of the long-term efficacy of strategies to prevent chronic Pseudomonas aeruginosa pulmonary infection in children with cystic fibrosis. Mostofian F; Alkadri J; Tang K; Thampi N; Radhakrishnan D Int J Infect Dis; 2019 Aug; 85():92-97. PubMed ID: 31132474 [TBL] [Abstract][Full Text] [Related]
2. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis. Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742 [TBL] [Abstract][Full Text] [Related]
3. Nebulized gentamicin in combination with systemic antibiotics for eradicating early Pseudomonas aeruginosa infection in children with cystic fibrosis. Van Stormbroek B; Zampoli M; Morrow BM Pediatr Pulmonol; 2019 Apr; 54(4):393-398. PubMed ID: 30656856 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Langton Hewer SC; Smyth AR Cochrane Database Syst Rev; 2009 Oct; (4):CD004197. PubMed ID: 19821321 [TBL] [Abstract][Full Text] [Related]
6. Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis. Mayer-Hamblett N; Kloster M; Rosenfeld M; Gibson RL; Retsch-Bogart GZ; Emerson J; Thompson V; Ramsey BW Clin Infect Dis; 2015 Sep; 61(5):707-15. PubMed ID: 25972024 [TBL] [Abstract][Full Text] [Related]
7. Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'. Treggiari MM; Rosenfeld M; Mayer-Hamblett N; Retsch-Bogart G; Gibson RL; Williams J; Emerson J; Kronmal RA; Ramsey BW; Contemp Clin Trials; 2009 May; 30(3):256-68. PubMed ID: 19470318 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study. Master V; Roberts GW; Coulthard KP; Baghurst PA; Martin A; Roberts ME; Onishko CR; Martin AJ; Linke RJ; Holmes M; Jarvinen A; Kennedy D; Colebatch KA; Hansman D; Parsons DW Pediatr Pulmonol; 2001 May; 31(5):367-76. PubMed ID: 11340683 [TBL] [Abstract][Full Text] [Related]
9. Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study. Tiddens HA; De Boeck K; Clancy JP; Fayon M; H G M A; Bresnik M; Derchak A; Lewis SA; Oermann CM; J Cyst Fibros; 2015 Jan; 14(1):111-9. PubMed ID: 25091537 [TBL] [Abstract][Full Text] [Related]
10. Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis. Mayer-Hamblett N; Rosenfeld M; Treggiari MM; Konstan MW; Retsch-Bogart G; Morgan W; Wagener J; Gibson RL; Khan U; Emerson J; Thompson V; Elkin EP; Ramsey BW; ; Pediatr Pulmonol; 2013 Oct; 48(10):943-53. PubMed ID: 23818295 [TBL] [Abstract][Full Text] [Related]
11. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Greally P; Whitaker P; Peckham D Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Wood DM; Smyth AR Cochrane Database Syst Rev; 2006 Jan; (1):CD004197. PubMed ID: 16437476 [TBL] [Abstract][Full Text] [Related]
13. Pseudomonas acquisition in young patients with cystic fibrosis: pathophysiology, diagnosis, and management. Rosenfeld M; Ramsey BW; Gibson RL Curr Opin Pulm Med; 2003 Nov; 9(6):492-7. PubMed ID: 14534401 [TBL] [Abstract][Full Text] [Related]
14. Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis. Gappa M; Steinkamp G; Tümmler B; von der Hardt H Scand J Gastroenterol Suppl; 1988; 143():74-6. PubMed ID: 3164515 [TBL] [Abstract][Full Text] [Related]
15. Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial. Mayer-Hamblett N; Retsch-Bogart G; Kloster M; Accurso F; Rosenfeld M; Albers G; Black P; Brown P; Cairns A; Davis SD; Graff GR; Kerby GS; Orenstein D; Buckingham R; Ramsey BW; Am J Respir Crit Care Med; 2018 Nov; 198(9):1177-1187. PubMed ID: 29890086 [TBL] [Abstract][Full Text] [Related]
16. Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis. Proesmans M; Vermeulen F; Boulanger L; Verhaegen J; De Boeck K J Cyst Fibros; 2013 Jan; 12(1):29-34. PubMed ID: 22762867 [TBL] [Abstract][Full Text] [Related]